Investigating genetic and biomarker predictors of Alzheimer's disease and related dementias
Genetic, Biomarker and Biospecimen Core
This study is looking at how genes and certain biological markers can help us understand how Alzheimer's disease and related dementias progress, and it's for people experiencing different stages of memory issues, like mild cognitive impairment.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10873096 on NIH RePORTER |
What this research studies
This research focuses on understanding how genetics and biomarkers can predict the clinical progression of Alzheimer's disease and related dementias. It involves collecting and analyzing biospecimens and genetic data from individuals at various stages of cognitive decline, including those with mild cognitive impairment and subjective cognitive decline. The study aims to create a comprehensive resource of biological samples that can be used for collaborative research, enhancing the understanding of disease susceptibility and progression. By leveraging unique patient populations and genomic resources, the research seeks to foster new directions in Alzheimer's research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, those experiencing mild cognitive impairment, and individuals showing early signs of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those not exhibiting any cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for predicting the onset and progression of Alzheimer's disease, potentially allowing for earlier interventions.
How similar studies have performed: Previous research has shown promise in using genetic and biomarker approaches to understand Alzheimer's disease, indicating that this methodology has potential for success.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Wilcock, Donna M — Indiana University Indianapolis
- Study coordinator: Wilcock, Donna M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.